1. AHRO : Austin Health Research Online

Hui K Gan

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Hui K Gan
Full Name
Gan, Hui K
 
Variants
Gan, Hui Kong
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 81-100 of 121 (Search time: 0.015 seconds).

Publication YearTitleAuthor(s)
818-Feb-2018Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.Aldape, Kenneth; Amin, Samirkumar B; Ashley, David M; Barnholtz-Sloan, Jill S; Bates, Amanda J; Beroukhim, Rameen; Bock, Christoph; Brat, Daniel J; Claus, Elizabeth B; Costello, Joseph F; de Groot, John F; Finocchiaro, Gaetano; French, Pim J; Gan, Hui K ; Griffith, Brent; Herold-Mende, Christel C; Horbinski, Craig; Iavarone, Antonio; Kalkanis, Steven N; Karabatsou, Konstantina; Kim, Hoon; Kouwenhoven, Mathilde C M; McDonald, Kerrie L; Miletic, Hrvoje; Nam, Do-Hyun; Ng, Ho Keung; Niclou, Simone P; Noushmehr, Houtan; Ormond, Ryan; Poisson, Laila M; Reifenberger, Guido; Roncaroli, Federico; Sa, Jason K; Sillevis Smitt, Peter A E; Smits, Marion; Souza, Camila F; Tabatabai, Ghazaleh; Van Meir, Erwin G; Verhaak, Roel G W; Watts, Colin; Wesseling, Pieter; Woehrer, Adelheid; Yung, W K Alfred; Jungk, Christine; Hau, Ann-Christin; van Dyck, Eric; Westerman, Bart A; Yin, Julia; Abiola, Olajide; Zeps, Nikolaj; Grimmond, Sean; Buckland, Michael; Khasraw, Mustafa; Sulman, Erik P; Muscat, Andrea M; Stead, Lucy
82Jan-2018Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors.Ameratunga, Malaka; Chénard-Poirier, Maxime; Moreno Candilejo, Irene; Pedregal, Manuel; Lui, Andrew; Dolling, David; Aversa, Caterina; Ingles Garces, Alvaro; Ang, Joo Ern; Banerji, Udai; Kaye, Stan; Gan, Hui K ; Doger, Bernard; Moreno, Victor; de Bono, Johann; Lopez, Juanita
832018Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies.Brastianos, Priscilla K; Ippen, Franziska Maria; Hafeez, Umbreen ; Gan, Hui K 
84Nov-2017Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.Gan, Hui K ; van den Bent, Martin; Lassman, Andrew B; Reardon, David A; Scott, Andrew M 
851-Oct-2017Changes in the use of end points in clinical trials for elderly cancer patients over time.Le Saux, O; Falandry, C; Gan, Hui K ; You, B; Freyer, G; Péron, J
86Aug-2017Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.Tamjid, Babak ; Phan, Phuong L; John, Thomas ; Mitchell, Paul L R ; Gan, Hui K 
876-Jul-2017Evolution of anti-HER2 therapies for cancer treatmentParakh, Sagun ; Gan, Hui K ; Parslow, Adam C; Burvenich, Ingrid JG; Burgess, Antony W; Scott, Andrew M 
881-Jul-2017Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastomaReardon, David A; Lassman, Andrew B; van den Bent, Martin; Kumthekar, Priya; Merrell, Ryan; Scott, Andrew M ; Fichtel, Lisa; Sulman, Erik P; Gomez, Erica; Fischer, JuDee; Lee, Ho-Jin; Munasinghe, Wijith; Xiong, Hao; Mandich, Helen; Roberts-Rapp, Lisa; Ansell, Peter; Holen, Kyle D; Gan, Hui K 
89Dec-2016A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsSoria, Jean-Charles; Gan, Hui K ; Blagden, SP; Plummer, R; Arkenau, HT; Ranson, M; Evans, TR; Zalcman, G; Bahleda, R; Hollebecque, A; Lemech, C; Dean, E; Brown, J; Gibson, D; Peddareddigari, V; Murray, S; Nebot, N; Mazumdar, J; Swartz, L; Auger, KR; Fleming, RA; Singh, R; Millward, M
90Nov-2016Temozolomide-associated liver fibrosisParakh, Sagun ; Hamid, Anis A; Cher, Lawrence M ; Gan, Hui K 
91Sep-2016In vitro and in vivo evaluation of 89Zr-DS-8273a as a theranostic for anti-death receptor 5 therapyBurvenich, Ingrid JG; Lee, Fook-Thean; Guo, Nancy; Gan, Hui K ; Rigopoulos, Angela; Parslow, Adam C; O'Keefe, Graeme J; Gong, Sylvia J; Tochon-Danguy, Henri J ; Rudd, Stacey E; Donnelly, Paul S; Kotsuma, Masakatsu; Ohtsuka, Toshiaki; Senaldi, Giorgio; Scott, Andrew M 
9211-Jul-2016Antibody-Drug Conjugates for Cancer Therapy.Parslow, Adam C; Parakh, Sagun ; Lee, Fook-Thean; Gan, Hui K ; Scott, Andrew M 
93Jun-2016Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.Burvenich, Ingrid J G; Parakh, Sagun ; Gan, Hui K ; Lee, Fook-Thean; Guo, Nancy; Rigopoulos, Angela; Lee, Sze-Ting; Gong, Sylvia; O'Keefe, Graeme J; Tochon-Danguy, Henri; Kotsuma, Masakatsu; Hasegawa, Jun; Senaldi, Giorgio; Scott, Andrew M 
94Feb-2016Recurrent glioblastoma: current patterns of care in an Australian populationParakh, Sagun ; Thursfield, Vicky; Cher, Lawrence M ; Dally, Michael; Drummond, Katharine J; Murphy, Michael; Rosenthal, Mark A; Gan, Hui K 
95Jan-2016Aggregated adverse-events outcomes in oncology phase III reports: A systematic review.Maillet, Denis; Gan, Hui K ; Blay, Jean-Yves; You, Benoit; Péron, Julien
96Jan-2016The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC membersMaillet, D; Blay, JY; You, B; Rachdi, A; Gan, Hui K ; Péron, Julien
972016Inclusion of elderly patients in oncology clinical trials.Le Saux, O; Falandry, C; Gan, Hui K ; You, B; Freyer, G; Péron, J
982016L-Tyrosine confers residualizing properties to a d-Amino acid-rich residualizing peptide for radioiodination of internalizing antibodiesLee, Fook T; Burvenich, Ingrid JG; Guo, Nancy; Kocovski, Pece; Tochon-Danguy, Henri; Ackermann, Uwe ; O’Keefe, Graeme J; Gong, Sylvia; Rigopoulos, Angela; Liu, Zhanqi; Gan, Hui K ; Scott, Andrew M 
992016Antibody-mediated delivery of therapeutics for cancer therapyParakh, Sagun ; Parslow, Adam C; Gan, Hui K ; Scott, Andrew M 
10029-Dec-2015Hypopharyngeal large cell neuroendocrine carcinomaLee, Wei-I; Ameratunga, Malaka; du Plessis, Justin; Gan, Hui K